Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 83,229 | -105,511 | -46,049 | -26,772 | -8,555 |
| Depreciation Amortization | 59,636 | 5,499 | 1,006 | 944 | 407 |
| Accounts receivable | -11,977 | 6,868 | -9,078 | -6,772 | 1,051 |
| Other Working Capital | -10,780 | 14,480 | 5,883 | -406 | -357 |
| Other Operating Activity | -121,706 | 8,999 | 14,703 | 14,289 | 17,893 |
| Operating Cash Flow | $-1,598 | $-69,665 | $-33,535 | $-18,717 | $10,439 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -387 | N/A | -296 | -93 | -102 |
| Net Acquisitions | N/A | N/A | -30,401 | -14,090 | N/A |
| Purchase Of Investment | -309,986 | -41,161 | -45,814 | -23,861 | -15,422 |
| Sale Of Investment | 328,500 | 25,000 | 59,121 | 1,325 | N/A |
| Other Investing Activity | 0 | -6,000 | 0 | 0 | 0 |
| Investing Cash Flow | $18,127 | $-22,161 | $-17,390 | $-36,719 | $-15,524 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 60,072 | 43,687 | 14,073 | 78,135 |
| Debt Repayment | -372 | -43,131 | -18,100 | -1,322 | -38,097 |
| Common Stock Issued | 12,436 | 67,258 | 6,324 | 324 | 80,104 |
| Common Stock Repurchased | N/A | N/A | -3,447 | -4,723 | -2,814 |
| Other Financing Activity | 0 | -2,091 | 0 | 0 | -4,219 |
| Financing Cash Flow | $12,064 | $82,108 | $28,464 | $8,352 | $113,109 |
| Exchange Rate Effect | 28 | 454 | 44 | 204 | N/A |
| Beginning Cash Position | 33,785 | 43,049 | 65,466 | 112,346 | 4,322 |
| End Cash Position | 62,406 | 33,785 | 43,049 | 65,466 | 112,346 |
| Net Cash Flow | $28,621 | $-9,264 | $-22,417 | $-46,880 | $108,024 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,598 | -69,665 | -33,535 | -18,717 | 10,439 |
| Capital Expenditure | -835 | 0 | -296 | -93 | -102 |
| Free Cash Flow | -2,433 | -69,665 | -33,831 | -18,810 | 10,337 |